{
    "response": "The priority is to confirm an inflammatory demyelinating process, exclude stroke or structural brainstem disease, document optic nerve involvement, and screen for metabolic, infectious, and autoimmune mimics and coexisting hypothyroidism before initiating disease-modifying therapy.\n\ninvestigations = [\"MRI of brain and cervical spine with gadolinium contrast\", \"MRI of orbits with gadolinium contrast\", \"Lumbar puncture with CSF oligoclonal bands, cell count, protein, glucose, and infectious PCR panel\", \"Visual evoked potentials\", \"Full blood count\", \"Urea and electrolytes\", \"Liver function tests\", \"C-reactive protein\", \"Erythrocyte sedimentation rate\", \"Thyroid-stimulating hormone\", \"Free T4\", \"Vitamin B12 level\", \"Serum folate level\", \"Serum glucose\", \"Coagulation screen\", \"Lipid profile\", \"Autoimmune screen including antinuclear antibody, extractable nuclear antigen panel, and antineutrophil cytoplasmic antibodies\", \"Serum aquaporin-4 antibody\", \"Myelin oligodendrocyte glycoprotein (MOG) antibody\", \"HIV antibody/antigen test\", \"Syphilis serology\", \"Lyme disease serology\", \"Thyroid peroxidase antibody\", \"ECG\", \"Chest X-ray\", \"Serum pregnancy test (beta-hCG)\"]"
}